K. Aho, M. Koskenvuo, J. Tuominen, and E. J. Kaprio, «Occurrence of rheumatoid arthritis in a nationwide series of twins, J Rheumatol, issue.5, pp.13899-902, 1986.

J. M. Albers, H. H. Kuper, P. L. Van-riel, M. L. Prevoo, M. A. Van-'t-hof et al., «Socioeconomic consequences of rheumatoid arthritis in the first years of the disease, » Rheumatology, issue.5, pp.38423-38453, 1999.

D. Aletaha, T. Neogi, and A. J. Silman, «Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Arthritis Rheum, issue.9, pp.622569-81, 2010.

R. Alten, Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release Prednisone, The Journal of Rheumatology, vol.37, issue.10, pp.372025-372056, 2010.
DOI : 10.3899/jrheum.100051

J. J. Anderson, G. Wells, A. C. Verhoeven, and D. T. Felson, Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration, Arthritis & Rheumatism, vol.4, issue.1, pp.43-65, 2000.
DOI : 10.1007/BF01857093

F. C. Arnett, S. M. Edworthy, and D. A. Block, «The American Rheumatism Association -revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, pp.31-315, 1988.

. Attract-study and . Group, «Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial.» Lancet, pp.1932-1939, 1999.

S. Y. Bang, K. H. Lee, S. K. Cho, H. S. Lee, K. W. Lee et al., «Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DBR1 shared épitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status, » Arthritis Rheum, issue.2, pp.62369-77, 2010.

J. Berthelot, Combe. «Efficacité, tolerance et maintien du méthotrexate dans le traitement des polyarthrites rhumatoïdes, » Revue du rhumatisme, pp.69-72, 2002.

L. Bessett, M. Camerlain, F. Morin, P. Raîche, and E. A. Turcotte, «Pour l'avancement de la rhumatologie.» Dans Cahier du participant, de Atelier de formation, 2004.

S. Blaschke, G. Schwarz, D. Moneke, L. Binder, and G. Müller, Reuss-Borst. «Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheumatoid arthritis, J Rheumatol, issue.4, pp.27866-73, 2000.

M. Boers, A. C. Verhoeven, H. M. Markusse, M. A. Van-de-laar, R. Westhovens et al., Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis, The Lancet, vol.350, issue.9074, pp.309-327, 1997.
DOI : 10.1016/S0140-6736(97)01300-7

I. Bouaddi, et al. «Les critères d'évaluation de la polyarthrite rhumatoïde.» Rhum, pp.19-23, 2012.

W. J. Boyle, «RANK Ligand : médiateur essentiel de la formation, fonction et survie des ostéoclates, Nature, pp.423-337, 2003.

P. Buttet, «Education concept for patient-centered care, » Rech Soins Infirm, vol.73, pp.41-48, 2003.

F. Buttgereit, Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.7, pp.691275-80, 2010.
DOI : 10.1136/ard.2009.126888

URL : http://ard.bmj.com/content/annrheumdis/69/7/1275.full.pdf

A. Cantagrel, «Prise en charge actuelle de la PR : les biothérapies.» La revue du praticien, 2012.

H. Chapel, M. Haeney, S. Misbah, and E. N. Snowden, Immunologie Clinique : De la théorie à la pratique, avec cas cliniques, p.358, 2004.

Y. Chen, A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness, Health Technology Assessment, vol.10, issue.42, pp.10-11, 2006.
DOI : 10.3310/hta10420

C. De and G. , «Fiches conseils de dispensation.» Documents internes du service de rhumatologie

B. Combe, Early rheumatoid arthritis: strategies for prevention and management, Best Practice & Research Clinical Rheumatology, vol.21, issue.1, pp.27-42, 2007.
DOI : 10.1016/j.berh.2006.08.011

B. Combe, «Polyarthrite rhumatoïde : diagnostic et aspects cliniques.» Dans Encyclopédie médicochirurgicale , 14-220-A-10, 2007.

B. Combe, «Polyarthrite rhumatoïde de l'adulte : traitement.» Dans Encyclopédie médico-chirurgicale, pp.1-23, 2006.
DOI : 10.1016/s0246-0521(06)35154-6

K. H. Costenbader, D. Feskanich, L. A. Mandl, and E. W. Karlson, Smoking Intensity, Duration, and Cessation, and the Risk of Rheumatoid Arthritis in Women, The American Journal of Medicine, vol.119, issue.6, pp.119503-119504, 2006.
DOI : 10.1016/j.amjmed.2005.09.053

M. Cutolo, B. Seriolo, B. Villaggio, C. Pizzorni, C. Craviotto et al., Androgens and Estrogens Modulate the Immune and Inflammatory Responses in Rheumatoid Arthritis, Annals of the New York Academy of Sciences, vol.19, issue.1, pp.131-173, 2002.
DOI : 10.1111/j.1749-6632.2002.tb04210.x

C. M. Deighton, J. Wentzel, and E. G. Cavanagh, Contribution of inherited factors to rheumatoid arthritis., Annals of the Rheumatic Diseases, vol.51, issue.2, pp.51182-51187, 1992.
DOI : 10.1136/ard.51.2.182

S. S. Deo, R. R. Shetty, K. J. Mistry, and A. R. Chogle, Detection of viral citrullinated peptide antibodies directed against EBV or VCP: In early rheumatoid arthritis patients of Indian origin, Journal of Laboratory Physicians, vol.2, issue.2, pp.293-302, 2010.
DOI : 10.4103/0974-2727.72158

K. Eberhardt, L. Rygdren, E. Fex, B. Svensson, and F. A. Wolleim, «D-penicillamine in early rheumatoid arthritis : experience from a 2-year double blind placebo controlled study, » Clin Exp Rheumatol, issue.6, pp.14625-14656, 1996.

D. T. Felson, «American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials, » Arthritis Rheum, issue.3, pp.63573-86, 2011.

J. Foucaud, M. Moquet, F. Rostan, E. Hamell, and E. A. Fayard, «Etat des lieux de la formation initiale en ETP du patient en France, résultat d'une analyse globale pour 10 professions de santé, » Evolution, vol.12, issue.12, pp.1-6, 2008.

R. I. Fox, M. Luppi, P. Pisa, and H. I. Kang, «Potential role of Epstein-Barr virus in Sjögren's syndrome and rheumatoid arthritis, J. Rheumatol, vol.32, pp.18-24, 1992.

S. E. Gabriel, C. S. Crowson, H. M. Kremers, M. F. Doran, C. Turesson et al., Survival in rheumatoid arthritis: A population-based analysis of trends over 40 years, Arthritis & Rheumatism, vol.48, issue.1, pp.4854-4862, 2003.
DOI : 10.1002/art.10705

C. Gaujoux-viala, Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.69, issue.6, pp.691004-691013, 2010.
DOI : 10.1136/ard.2009.127225

C. Gaujoux-vialaa, Recommandations de la Soci??t?? fran??aise de rhumatologie pour la prise en charge de la polyarthrite rhumato??de, Revue du Rhumatisme, vol.81, issue.4, pp.303-312, 2014.
DOI : 10.1016/j.rhum.2014.04.009

A. Gough, Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome, Arthritis & Rheumatism, vol.89, issue.8, pp.371166-70, 1994.
DOI : 10.1002/art.1780370809

L. W. Green, M. W. Kreuter, S. G. Deeds, and K. B. Partridge, Health education planning : a diagnostic approach, 1980.

F. Guillemin, C. Bregeon, J. Coste, J. Pouchot, R. Dropsy et al., Le questionnaire EMIR court pour les ??tudes longitudinales de la qualit?? de vie dans la polyarthrite rhumato??de, Annales de Réadaptation et de Médecine Physique, pp.43-229, 2000.
DOI : 10.1016/S0168-6054(00)89086-8

M. Hamad and . Ben, «Signal transducer and activator of transcription and the risk of rheumatoid arthritis and thyroid autoimmune disorders, » Clin Exp Rheumatol, issue.2, pp.29269-74, 2011.

P. Hannonen, T. Möttönen, M. Hakola, and E. M. Oka, Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study, Arthritis & Rheumatism, vol.21, issue.11, pp.361501-1509, 1993.
DOI : 10.1001/jama.1949.02900430001001

H. and H. Autorité-de-santé, Polyarthrite rhumatoide : aspects thérapeutiques hors médicaments et chirurgie -aspects médico-sociaux et organisationnels. Service communication, 2007.

M. C. Husson, «Polyarthrite rhumatoïde : stratégie thérapeutique.» Dossier du CNHIM (centre national hospitalie d'in o mation su le médicament), Août-septembre, 2003.

H. Kallberg, Gene-Gene and Gene-Environment Interactions Involving HLA-DRB1, PTPN22, and Smoking in Two Subsets of Rheumatoid Arthritis, The American Journal of Human Genetics, vol.80, issue.5, pp.80867-75, 2007.
DOI : 10.1086/516736

J. R. Kirwan, SYSTEMIC LOW-DOSE GLUCOCORTICOID TREATMENT IN RHEUMATOID ARTHRITIS, Rheumatic Disease Clinics of North America, vol.27, issue.2, pp.389-403, 2001.
DOI : 10.1016/S0889-857X(05)70208-8

M. Korpela, Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: Five-year experience from the FIN-RACo study, Arthritis & Rheumatism, vol.43, issue.Suppl, pp.502072-81, 2004.
DOI : 10.1002/1529-0131(200011)43:11<2397::AID-ANR4>3.0.CO;2-V

N. Kusunoki, Adiponectin stimulates prostaglandin E2 production in rheumatoid arthritis synovial fibroblasts, Arthritis & Rheumatism, vol.16, issue.6, pp.621641-621650, 2010.
DOI : 10.1172/JCI0215528

URL : http://onlinelibrary.wiley.com/doi/10.1002/art.27450/pdf

A. Lafitte, Nouvelles cibles thérapeutiques dans la polyarthrite rhumatoïde et essor de biothérapies innovantes., [thèse d'exercice], p.388, 2007.

B. A. Lie, Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study, Annals of the Rheumatic Diseases, vol.66, issue.12
DOI : 10.1136/ard.2006.067892

M. T. Malaval, J. Quintrec, J. Giraudet, and E. A. Kahan, «opinion de patients et professionnels de santé sur un entretien à visée éducative (diagnostic éducatif) pour des patients atteints de polyarthrite rhumatoïde, Education du patient et enjeu de santé, p.1, 2006.

A. T. Masi, J. C. Aldag, R. T. Chatterton, R. F. Adams, and A. E. Kitabchi, Die Dissoziation adrenaler Androgene und Glukokortikoide bei pr??menopausaler rheumatoider Arthritis: ein wichtiger Pr??diktor der Manifestation?, Zeitschrift f??r Rheumatologie, vol.59, issue.S2, pp.5954-61, 2000.
DOI : 10.1007/s003930070019

A. T. Masi, S. L. Feigenbaum, and R. T. Chatterton, Hormonal and pregnancy relationships to rheumatoid arthritis: Convergent effects with immunologic and microvascular systems, Seminars in Arthritis and Rheumatism, vol.25, issue.1, pp.251-278, 1995.
DOI : 10.1016/S0049-0172(95)80014-X

C. J. Menkès, Y. Allanore, J. Giraudet-le-quintrec, P. Hilliquin, H. Judet et al., La polyarthrite humatoïde de l'adulte, 2004.

E. F. Morand, M. Et, and . Leech, Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis, Immunology and Cell Biology, vol.43, issue.4, pp.79395-79404, 2001.
DOI : 10.1002/1529-0131(200004)43:4<827::AID-ANR13>3.0.CO;2-K

D. E. Morisky, L. W. Green, and D. M. Levine, Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence, Medical Care, vol.24, issue.1, pp.2467-74, 1986.
DOI : 10.1097/00005650-198601000-00007

T. Möttönen, «Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis, » Arthritis Rheum, issue.4, pp.46894-46902, 2002.

J. E. Oliver, A. J. Et, and . Silman, Risk factors for the development of rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.59, issue.3, pp.35169-74, 2006.
DOI : 10.1136/ard.59.7.533

R. A. Overman, J. C. Toliver, J. Y. Yeh, M. L. Gourlay, and C. L. Deal, «U.S. adults meeting 2010 American College of Rheumatology criteria for treatment and prevention of glucocorticoid-induced osteoporosis, Arthritis Care Res, issue.7, pp.441496-1503

G. Pasero, P. Pellegrini, U. Ambanelli, M. L. Ciompi, V. Colamussi et al., Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis, Arthritis & Rheumatism, vol.70, issue.8, pp.923-929, 1982.
DOI : 10.7326/0003-4819-69-3-549

X. Phelip, «The rheumatoid arthritis school : a form of teamwork : rheumatology, state of the art, » Rheumatology, pp.427-428, 1992.

R. S. Pinals, S. B. Kaplan, J. G. Lawson, and E. B. Hepburn, «Sulfasalazine in rheumatoid arthritis. A doubleblind , placebo-controlled trial, Arthritis Rheum, issue.4, p.30459, 1987.

R. M. Plenge, M. Seielstad, and E. L. Padyukov, as a Risk Locus for Rheumatoid Arthritis ??? A Genomewide Study, New England Journal of Medicine, vol.357, issue.12, pp.1199-1209, 2007.
DOI : 10.1056/NEJMoa073491

F. Pratesi, C. Tommasi, C. Anzilotti, D. Chimenti, and E. P. Migliorini, Deiminated Epstein-Barr virus nuclear antigen 1 is a target of anti???citrullinated protein antibodies in rheumatoid arthritis, Arthritis & Rheumatism, vol.44, issue.3, pp.54733-54774, 2006.
DOI : 10.4049/jimmunol.171.2.538

M. L. Prevoo, A. M. Van-gestel, M. A. Van, and T. Hof, REMISSION IN A PROSPECTIVE STUDY OF PATIENTS WITH RHEUMATOID ARTHRITIS. AMERICAN RHEUMATISM ASSOCIATION PRELIMINARY REMISSION CRITERIA IN RELATION TO THE DISEASE ACTIVITY SCORE, Rheumatology, vol.35, issue.11, pp.351101-351106, 1996.
DOI : 10.1093/rheumatology/35.11.1101

E. Radideau, S. Bah, C. Dupont, and E. P. Hilliquin, «Polyarthrite rhumatoïde (1ère partie) : nouvelles biothérapies ciblant les cellules du système immunitaire, rituximab et abatacept.» Dossier du CNHIM (cent e national hospitalie d'in o mation su le médicament), p.5, 2010.

J. Roos, B. Allenet, P. Gaudin, R. Juvin, and E. J. Calop, «Education thérapeutique des patients atteints de polyarthrite rhumatoïde : description du programme MédiPR, Journal de Pharmacie Clinique, issue.4, pp.24-217, 2005.

S. Clair and S. T. , «Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.» Arthritis rheum, pp.3432-3443, 2004.

F. Salaffi, M. Carotti, and C. Cervini, Combination Therapy of Cyclosporine a with Methotrexate or Hydroxychloroquine in Refractory Rheumatoid Arthritis, Scandinavian Journal of Rheumatology, vol.10, issue.2, pp.2516-2539, 1996.
DOI : 10.1002/art.1780360821

J. Sany, La polya th ite humatoïde de l'adulte, p.297, 2003.

J. Sany, Characteristics of patients with rheumatoid arthritis in France: a study of 1109 patients managed by hospital based rheumatologists, Annals of the Rheumatic Diseases, vol.63, issue.10, pp.631235-631275, 2004.
DOI : 10.1136/ard.2003.013110

A. Saraux, J. M. Berthelot, G. Chales, C. Henaff, J. B. Le-thorel et al., Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later, Arthritis & Rheumatism, vol.42, issue.11, pp.442485-91, 2001.
DOI : 10.1002/1529-0131(199907)42:7<1339::AID-ANR6>3.0.CO;2-Y

J. T. Sharp, D. Y. Young, G. B. Bluhm, A. Brook, and A. C. Brower, How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?, Arthritis & Rheumatism, vol.12, issue.12, pp.281326-281361, 1985.
DOI : 10.1111/j.1399-6576.1965.tb00488.x

A. Silman, J. «Problems complicating the genetic epidemiology of rheumatoid arthritis, J Rheumatol, vol.24, issue.1, pp.194-200, 1997.

A. J. Silman, TWIN CONCORDANCE RATES FOR RHEUMATOID ARTHRITIS: RESULTS FROM A NATIONWIDE STUDY, Rheumatology, vol.32, issue.10, pp.32903-32910, 1993.
DOI : 10.1093/rheumatology/32.10.903

J. S. Smolen, J. R. Kalden, D. L. Scott, B. Rozman, T. K. Kvien et al., Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial, The Lancet, vol.353, issue.9149, pp.259-66, 1999.
DOI : 10.1016/S0140-6736(98)09403-3

D. H. Solomon, E. W. Karlson, E. B. Rimm, C. C. Cannuscio, L. A. Mandl et al., Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis, Circulation, vol.107, issue.9, pp.1303-1310, 2003.
DOI : 10.1161/01.CIR.0000054612.26458.B2

P. Stolt, C. Bengtsson, B. Nordmark, S. Lindblad, I. Lundberg et al., Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases, Annals of the Rheumatic Diseases, vol.62, issue.9, pp.62835-62876, 2003.
DOI : 10.1136/ard.62.9.835

D. Sugiyama, K. Nishimura, K. Tamaki, G. Tsuji, T. Nakazawa et al., Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies, Annals of the Rheumatic Diseases, vol.69, issue.01
DOI : 10.1136/ard.2008.096487

S. W. Syversen, G. L. Goll, D. Van-der-heijde, R. Landewe, B. A. Lei et al., Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study, Annals of the Rheumatic Diseases, vol.69, issue.2, pp.69345-51, 2010.
DOI : 10.1136/ard.2009.113092

T. Takeda, Y. Mizugaki, L. Matsubara, S. Imai, T. Koike et al., Lytic Epstein???Barr virus infection in the synovial tissue of patients with rheumatoid arthritis, Arthritis & Rheumatism, vol.43, issue.6, pp.431218-431243, 2000.
DOI : 10.1002/1529-0131(200006)43:6<1218::AID-ANR4>3.0.CO;2-2

G. Tong, X. Zhang, W. Tong, and E. Y. Liu, Association between polymorphism in STAT4 gene and risk of rheumatoid arthritis: A meta-analysis, Human Immunology, vol.74, issue.5, pp.74586-92
DOI : 10.1016/j.humimm.2012.11.033

E. Toussirot, J. Et, and . Roudier, Pathophysiological links between rheumatoid arthritis and the Epstein???Barr virus: An update, Joint Bone Spine, vol.74, issue.5, pp.418-444, 2007.
DOI : 10.1016/j.jbspin.2007.05.001

URL : https://hal.archives-ouvertes.fr/hal-00465205

P. Tugwell, Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis, New England Journal of Medicine, vol.333, issue.3, pp.137-178, 1920.
DOI : 10.1056/NEJM199507203330301

A. A. Van-everdingen, D. R. Siewertsz-van-reesema, J. W. Jacobs, and J. W. Bijlsma, The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies, Arthritis Care & Research, vol.43, issue.Suppl 9, pp.51233-51241, 2004.
DOI : 10.1002/1529-0131(200012)43:12<2751::AID-ANR15>3.0.CO;2-6

K. Visser, Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative, Annals of the Rheumatic Diseases, vol.68, issue.7, pp.681086-1093, 2009.
DOI : 10.1136/ard.2008.094474

J. A. Wessels, T. W. Huizinga, and H. J. Guchelaar, Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis, Rheumatology, vol.47, issue.3, pp.47249-55, 2008.
DOI : 10.1093/rheumatology/kem279

R. L. Wilder, «Adrenal and gonadal steroid hormone deficiency in the pathogenesis of rheumatoid arthritis, » J Rheumatol, vol.44, pp.10-12, 1996.

N. J. Wiles, M. Lunt, E. M. Barrett, A. J. Silman, D. P. Symmons et al., Reduced disability at five years with early treatment of inflammatory polyarthritis: Results from a large observational cohort, using propensity models to adjust for disease severity, Arthritis & Rheumatism, vol.37, issue.5, pp.441033-441075, 2001.
DOI : 10.7326/0003-4819-124-8-199604150-00001

F. Wolfe, The mortality of rheumatoid arthritis, Arthritis & Rheumatism, vol.18, issue.4, pp.481-94, 1994.
DOI : 10.3109/rhe1.1969.15.issue-1-4.28

J. Zhao, G. Li, J. Xu, X. Zhang, and Z. I. Zhang, European League Against Rheumatism 2010 criteria for the diagnosis of rheumatoid arthritis in Chinese patients, Joint, pp.80-482, 2010.

L. Abbvie, Parcours Bon Usage anti-TNF alpha, 2008.

A. and A. Nationale-de-défense-contre-l-'arthrite-rhumatoïde, «Bien connaître HUMIRA®, Pour mieux vivre son traitement.» Polyarthrite-ANDAR, 2011.

C. De and G. , Education Thérapeutique du Patient. Octobre 2013

B. Combe, «Pronostic à long terme des patients atteints de polyarthrite rhumatoïde.» Société Française de Rhumatologie, 2006.

D. R. Bertholon, «Les Journées de la Prévention -Portfolio APPRIVOISER.» INPES - SANTE. Édité par INPES -SANTE. Mars, 2007.

W. Gerhard, Questionnaire sur votre Education Thérapeutique, 2014.

G. Cri, «Dossier pratique.» Groupe d'Experts Spécialisés dans la Polyarthrite Rhumatoïde. CRI : Club du Rhumatisme et de l'Inflammation

?. «commision-de-transparence, Avis Mabthera® 2012, 2012.

?. «guide-méthodologique and H. , St uctu ation d'un p og amme d'éducation thé apeutique du patient dans le champ des maladies chroniques, 2007.

?. «polyarthrite-rhumatoïde, synthèse des recommandations.» Recommandations professionnelles, 2007.

. La-clinique-du-pied, La clinique du pied, 2011.

L. Medipedia and . Encyclopédie-des-maladies, Les symptomes de la polyarthrites rhumatoides http://fr.medipedia.be/picture_polyarthrite_polyarthrite:-inflammation-de- l'articulation_10607_10657&src=http://fr.medipedia.be/Files/media/photos/Polyarthrite/Ga llery/inflammation-articulation_en-images.jpg?, pp.670-420, 2014.

L. Ministère-de and . Santé, «Plan pour l'amélioration de la qualité de vie des personnes atteintes de maladies chroniques et des Solidarités.» Site Web du Ministère de la Santé. 2007. www.sante-jeunesse-sports.gouv.fr/dossiers/sante/maladies-chroniques/plan-pouramelioration-qualite-vie-personnes-atteintes

C. Remedios and . «polyarthrite-rhumatoïde, http://www.clubortho.fr. DIU européen de chirurgie de la main et des nerfs périphériques, 2005.

S. Française-de-rhumatologie, Qu-est-ce-que-la-rhumatologie ? 2012

O. Vittecoq, «Société Française de Rhumatologie : flash-conférence.» Polyarthrite rhumatoïde. 23 ème congrès, 2010.

. Manger-f-tes--yous-capable-de, ? Ci:l.Jper \IOCre vunde

@. Otm-'lr-une, bnque" de bn ou de JUS de l'n